VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU
Abstract Cell cycle checkpoint kinases play a pivotal role in protecting against replicative stress. In this study, valproic acid (VPA), a histone deacetylase inhibitor (HDACi), was found to promote breast cancer MCF-7 cells to traverse into G2/M phase for catastrophic injury by promoting PPP2R2A (t...
Main Authors: | Benyu Su, David Lim, Chenyang Qi, Zhongwei Zhang, Junxiao Wang, Fengmei Zhang, Chao Dong, Zhihui Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-05649-8 |
Similar Items
-
Phosphatase POPX2 interferes with cell cycle by interacting with Chk1
by: Kim, Pu Rum, et al.
Published: (2022) -
Targeting the ATR-CHK1 Axis in Cancer Therapy
by: Stuart Rundle, et al.
Published: (2017-04-01) -
Analysis of variability of concentrations of valproic acid (VPA) and its selected metabolites in the blood serum of patients treated with VPA and patients hospitalized because of VPA poisoning
by: Jolanta Wilimowska, et al.
Published: (2015-03-01) -
A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization
by: Chunlu Li, et al.
Published: (2024-04-01) -
The SKP2‐p27 axis defines susceptibility to cell death upon CHK1 inhibition
by: Michael Lohmüller, et al.
Published: (2022-08-01)